An Intrabody against B-Cell Receptor-Associated Protein 31 (BAP31) Suppresses the Glycosylation of the Epithelial Cell-Adhesion Molecule (EpCAM) via Affecting the Formation of the Sec61-Translocon-Associated Protein (TRAP) Complex
The epithelial cell-adhesion molecule (EpCAM) is hyperglycosylated in carcinoma tissue and the oncogenic function of EpCAM primarily depends on the degree of glycosylation. Inhibiting EpCAM glycosylation is expected to have an inhibitory effect on cancer. We analyzed the relationship of BAP31 with 8...
Main Authors: | Tianyi Wang, Changli Wang, Jiyu Wang, Bing Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/19/14787 |
Similar Items
-
Knockdown of BAP31 Overcomes Hepatocellular Carcinoma Doxorubicin Resistance through Downregulation of Survivin
by: Jingjing Liu, et al.
Published: (2023-04-01) -
BAP31 Promotes Angiogenesis via Galectin-3 Upregulation in Neuroblastoma
by: Mwichie Namusamba, et al.
Published: (2024-03-01) -
Anti-tau intrabodies: From anti-tau immunoglobulins to the development of functional scFv intrabodies
by: Dina Rodrigues Martins, et al.
Published: (2023-12-01) -
Intrabody-Induced Cell Death by Targeting the T. brucei Cytoskeletal Protein TbBILBO1
by: Christine E. Broster Reix, et al.
Published: (2021-10-01) -
A toolbox of nanobodies developed and validated for use as intrabodies and nanoscale immunolabels in mammalian brain neurons
by: Jie-Xian Dong, et al.
Published: (2019-09-01)